Ondine Biomedical Balance Sheet Health
Financial Health criteria checks 5/6
Ondine Biomedical has a total shareholder equity of CA$4.1M and total debt of CA$281.0K, which brings its debt-to-equity ratio to 6.8%. Its total assets and total liabilities are CA$7.4M and CA$3.3M respectively.
Key information
6.8%
Debt to equity ratio
CA$281.00k
Debt
Interest coverage ratio | n/a |
Cash | CA$4.44m |
Equity | CA$4.15m |
Total liabilities | CA$3.26m |
Total assets | CA$7.41m |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: OBI's short term assets (CA$6.2M) exceed its short term liabilities (CA$2.7M).
Long Term Liabilities: OBI's short term assets (CA$6.2M) exceed its long term liabilities (CA$610.0K).
Debt to Equity History and Analysis
Debt Level: OBI has more cash than its total debt.
Reducing Debt: Insufficient data to determine if OBI's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: OBI has sufficient cash runway for 3 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: OBI is forecast to have sufficient cash runway for 2 months based on free cash flow estimates, but has since raised additional capital.